IRIS
PICCIOTTO, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.049
EU - Europa 980
AS - Asia 176
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.045
SE - Svezia 267
IE - Irlanda 227
IT - Italia 186
CN - Cina 146
UA - Ucraina 73
PL - Polonia 55
DE - Germania 49
FI - Finlandia 34
GB - Regno Unito 34
FR - Francia 32
BE - Belgio 17
SG - Singapore 15
IN - India 9
CA - Canada 4
RU - Federazione Russa 4
JP - Giappone 3
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EU - Europa 1
IR - Iran 1
NO - Norvegia 1
RO - Romania 1
Totale 2.207
Salva come PNG Salva come JPEG
Città #
Dublin 227
Chandler 212
Jacksonville 151
Nyköping 130
New York 70
Beijing 60
Ann Arbor 53
Warsaw 52
Ashburn 45
Dearborn 43
Messina 37
Princeton 37
Cambridge 35
Des Moines 33
Medford 31
Boardman 24
Brussels 17
Woodbridge 15
Wilmington 13
Hebei 12
Jinan 12
Nanjing 12
Shenyang 11
San Mateo 10
Lancaster 9
Leawood 8
Singapore 8
Los Angeles 7
Taizhou 7
Houston 6
Ningbo 6
Seattle 6
Augusta 4
Tianjin 4
Auburn Hills 3
Carbonia 3
Guangzhou 3
Pune 3
Radomsko 3
Rome 3
Toronto 3
Changsha 2
Clearwater 2
Dong Ket 2
Falls Church 2
Genova 2
Grammichele 2
Hefei 2
Melito Irpino 2
Monmouth Junction 2
Sassari 2
Taiyuan 2
Torino 2
Villar Perosa 2
Zhengzhou 2
Ardabil 1
Bangalore 1
Beinasco 1
Bergamo 1
Bologna 1
Brescia 1
Calderara Di Reno 1
Cardano 1
Castell'arquato 1
Chicago 1
Concorezzo 1
Dallas 1
Forest City 1
Fort Washington 1
Fuzhou 1
Haikou 1
Hangzhou 1
Hyderabad 1
Jiaxing 1
Kemerovo 1
Kumamoto 1
Kunming 1
Lanzhou 1
Lendinara 1
Marnate 1
Milan 1
Milazzo 1
Mola Di Bari 1
Monza 1
Mumbai 1
Nanchang 1
Novokuznetsk 1
Parabita 1
Parma 1
Quartu Sant'elena 1
Rivarolo Canavese 1
Rivoli 1
Romano di Lombardia 1
San Giorgio A Cremano 1
San Giuliano Milanese 1
Sant'antimo 1
Sant'oreste 1
Santa Clara 1
Scicli 1
Seano 1
Totale 1.501
Salva come PNG Salva come JPEG
Nome #
Linfoscintigrafia ascellare preoperatoria nel cancro della mammella. 238
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC). 117
Trattamento endoscopico scleroterapico nelle neoplasie sanguinanti del tratto digestivo. 75
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 73
COMPARISON OF GASTRIC BRUSH CYTOLOGY AND BIOPSY IN DETECTION OF INFECTION BY HELICOBACTER-PYLORI 72
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario 69
Trattamento palliativo dei tumori del retto-sigma mediante elettrocoagulazione endoscopica.” 68
INCIDENZA DELL'ONCOTIPO POLMONARE NELLO STESSO TERRITORIO IN TRIENNI DIFFERENTI- 1983/84/85 E 1993/94/95. Eur. Jour. of Oncology Vol. 2, n° 4, 1997. 67
“Significato diagnostico dei markers tumorali nel succo gastrico e nel siero di pazienti affetti da neoplasia gastrica.” 67
AMIFOSTINE IN CONJUCTION WITH H.D. VP16 AND G-CSF ENABLE PBSC COLLECTION IN MULTIPLE MYELOMA PATIENTS WHO FAILED CTX INDUCED MOBILIZATION 66
Gefitinib versus Erlotinib treatment in Non Small Cell Lung Cancer (NSCLC): comparison of two clinical experiences. 66
Safety of Capecitabine plus Bevacizumab in heavily treated patients with metastatic colorectal cancer (MCRC) 66
A modified weekly docetaxel schedule as first-line chemotherapy in elderly metastatic breast cancer: A safety study 64
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. 64
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 64
HELICOBACTER-PYLORI IN GASTRODUODENAL DISEASES - RAPID IDENTIFICATION BY ENDOSCOPIC BRUSH CYTOLOGY 61
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: 60
Endobronchial electrocautery for the dehydration of lung cancer. 56
First Line Chemotherapy with Oral Vinorelbine (oV) in Elderly Hormone-Refractory Prostate Cancer (HRPC) Patients (pts 54
Vinorelbina orale (OV) come trattamento chemioterapico di prima linea nel carcinoma mammario ormonorefrattario (HRPC) dell'anziano. 54
ANCHE IN VIVO IL PAMIDRONATO E' UN INDUTTORE DELLA APOPTOSI NELLE PLASMACELLULE MIELOMATOSE 54
Terapia con Pamidronato disodico e induzione della apoptosi nelle plasmacellule mielomatose. 53
Incidenza dell’oncotipo polmonare nello stesso territorio in trienni differenti 1983/84/85 e 1993/94/95. 53
Oral vinorelbine as first-line chemoptherapy in elderly patients with hormone-refractory prostate cancer. 51
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: a case report. 51
Fine needle aspiration to improve the diagnosis in lung cancer. 50
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 48
Emerging targeted therapies for castration-resistant prostate cancer 47
Ruolo della fibrobroncoscopia nella diagnosi dei tumori polmonari: revisione di 10 anni di casistica. 43
Somministrazione Locale di VP-16 attraverso il fibrobroncoscopio nelle neoplasie polmonari inoperabili a sviluppo endobronchiale. 43
Palliative treatment of rectosigmoid tumors by endoscopic electrocoagulation 41
Role of virtual colonoscopy following incomplete optical colonoscopy: our experience 40
Impact of erlotinib on overall survival in non small cell lung cancer patients: is the post progression survival a new paradigm? 39
TUMORS OF THE AMPULLA DIAGNOSED BY CT HYPOTONIC DUODENOGRAPHY 38
MYELODYSPLASTIC SYNDROMES DEVELOPING DURING IMATINIB THERAPY FOR GIST 38
Re-treatment with gefitinib or treatment with erlotinib after gefitinib failure in responsive non small cell lung cancers: new strategies to overcome acquired resistance. 24
Totale 2.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.643
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020270 0 20 3 14 2 47 42 32 6 34 56 14
2020/2021323 37 8 61 22 17 30 12 19 7 43 49 18
2021/2022275 3 43 4 8 11 3 15 5 4 72 36 71
2022/2023737 53 79 33 71 68 80 4 36 281 4 15 13
2023/2024186 20 15 12 14 9 83 18 2 1 5 0 7
2024/202512 7 5 0 0 0 0 0 0 0 0 0 0
Totale 2.234